Publications by authors named "C Bucelli"

Claim this Profile
B
Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.
Alessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, Chiara Elena, Mariella D'Adda

Acta Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis.
Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Cristina Bucelli

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Levels of PF4/CXCL4 in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression.
Valentina Bellani, Daniele Cattaneo, Vittorio Abbonante, Cristina Bucelli, Simona Stella

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects.
Alessandra Trojani, Ester Pungolino, Barbara Di Camillo, Luca Emanuele Bossi, Cassandra Palumbo, Cristina Bucelli

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study.
Simona Bernardi, Alessia Cavalleri, Silvia Mutti, Luca Garuffo, Mirko Farina, Cristina Bucelli

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis